Detailansicht

Kiss, A., Wu, P., Schlederer, M., Pilz, P. M., Szabo, P. L., Li, J., Weber, L., Vraka, C., Pichler, V., Mitterhauser, M., Zhang, X., Zins, K., Abraham, D., Li, S., Podesser, B. K., Hacker, M., & Li, X. (2022). Sympathetic nerve innervation and metabolism in ischemic myocardium in response to remote ischemic perconditioning. Basic research in cardiology, 117(1), [42]. https://doi.org/10.1007/s00395-022-00946-3

Bamminger, K., Raitanen, J., Karanikas, G., Rasul, S., Nics, L., Mitterhauser, M., Wadsak, W., Hacker, M., Pichler, V., & Vraka, C. (2022). Rapid, high-yield enzymatic synthesis of n.c.a. 6-[¹⁸F]fluorodopamine (6-[¹⁸F]FDA) for in vivo application. Nuclear Medicine and Biology, 114-115, 189-197. https://doi.org/10.1016/j.nucmedbio.2022.07.001

Klebermass, E. M., Dengler, A., Weissenböck, V., Ricken, G., Wadsak, W., Viernstein, H., Hacker, M., Mitterhauser, M., & Philippe, C. (2022). Autoradiography on deparaffinized tissue sections – A feasibility study with ⁶⁸Ga-labeled PET-tracers. Applied Radiation and Isotopes, 189, [110425]. https://doi.org/10.1016/j.apradiso.2022.110425

Bencurova, K., Friske, J., Anderla, M., Mayrhofer, M., Wanek, T., Nics, L., Egger, G., Helbich, T. H., Hacker, M., Haug, A., Mitterhauser, M., & Balber, T. (2022). CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [⁶⁸Ga]Ga-Pentixafor in CRC Imaging. Cancers, 14(22), [5549]. https://doi.org/10.3390/cancers14225549

Balber, T., Raitanen, J., Benčurová, K., Franssen, T., Schwarzl, P., Kalla, J., Culig, Z., Hacker, M., Egger, G., & Mitterhauser, M. (2022). In vitro investigation of a potential complementary expression of the imaging biomarkers AR and PSMA during prostate cancer progression. European Journal of Nuclear Medicine and Molecular Imaging, 49(SUPPL 1), S329-S330.

Rischka, L., Vraka, C., Pichler, V., Rasul, S., Nics, L., Gryglewski, G., Handschuh, P., Murgas, M., Godbersen, G. M., Silberbauer, L. R., Unterholzner, J., Wotawa, C., Haider, A., Ahmed, H., Schibli, R., Mindt, T., Mitterhauser, M., Wadsak, W., Hahn, A., ... Ametamey, S. M. (2022). First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-D-aspartate Receptor with (R)-C-11-Me-NB1. Journal of Nuclear Medicine, 63(6), 936-941. https://doi.org/10.2967/jnumed.121.262427

Rasul, S., Beitzke, D., Wollenweber, T., Rausch, I., Lassen, M. L., Stelzmüller, M. E., Mitterhauser, M., Pichler, V., Beyer, T., Loewe, C., & Hacker, M. (2022). Assessment of left and right ventricular functional parameters using dynamic dual-tracer [¹³N]NH3 and [¹⁸F]FDG PET/MRI. Journal of Nuclear Cardiology, 29(3), 1003-1017. https://doi.org/10.1007/s12350-020-02391-y

Vraka, C., Murgaš, M., Rischka, L., Geist, B. K., Lanzenberger, R., Gryglewski, G., Zenz, T., Wadsak, W., Mitterhauser, M., Hacker, M., Philippe, C., & Pichler, V. (2022). Simultaneous radiomethylation of [¹¹C]harmine and [¹¹C]DASB and kinetic modeling approach for serotonergic brain imaging in the same individual. Scientific Reports, 12(1), [3283]. https://doi.org/10.1038/s41598-022-06906-0

Balber, T., Tran, L., Bencurova, K., Raitanen, J., Egger, G., & Mitterhauser, M. (2022). Experimental Nuclear Medicine Meets Tumor Biology. Pharmaceuticals, 15(2), [227]. https://doi.org/10.3390/ph15020227

Rischka, L., Murgaš, M., Pichler, V., Vraka, C., Rausch, I., Winkler, D., Nics, L., Rasul, S., Silberbauer, L. R., Reed, M. B., Godbersen, G. M., Unterholzner, J., Handschuh, P., Gryglewski, G., Mindt, T., Mitterhauser, M., Hahn, A., Ametamey, S. M., Wadsak, W., ... Hacker, M. (2022). Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[¹¹C]Me-NB1. EJNMMI Research, 12(1), [53]. https://doi.org/10.1186/s13550-022-00925-8

Calabretta, R., Staber, P. B., Kornauth, C., Lu, X., Binder, P., Pichler, V., Mitterhauser, M., Haug, A., Li, X., & Hacker, M. (2021). Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age. Biology, 10(11), [1206]. https://doi.org/10.3390/biology10111206

Rischka, L., Vraka, C., Pichler, V., Rasul, S., Nics, L., Gryglewski, G., Handschuh, P., Murgas, M., Godbersen, G. M., Silberbauer, L. R., Unterholzner, J., Wotawa, C., Haider, A., Ahmed, H., Schibli, R., Mindt, T., Mitterhauser, M., Wadsak, W., Hahn, A., ... Ametamey, S. M. (2021). First-in-human mapping of the GluN2B subunits of the N-methyl-D-aspartate receptor using (R)-[(11)Cc]Me-NB1 and PET. European Journal of Nuclear Medicine and Molecular Imaging, 48(SUPPL 1), 296.

Klebermass, E-M., Mahmudi, M., Geist, B. K., Pichler, V., Vraka, C., Balber, T., Miller, A., Haschemi, A., Viernstein, H., Rohr-Udilova, N., Hacker, M., & Mitterhauser, M. (2021). If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[18F]FDG Metabolism. Pharmaceuticals, 14(9), [910]. https://doi.org/10.3390/ph14090910

Philippe, C., Klebermass, E-M., Balber, T., Kulterer, O. C., Zeilinger, M., Egger, G., Dumanic, M., Herz, C. T., Kiefer, F. W., Scheuba, C., Scherer, T., Fuernsinn, C., Vraka, C., Pallitsch, K., Spreitzer, H., Wadsak, W., Viernstein, H., Hacker, M., & Mitterhauser, M. (2021). Discovery of melanin-concentrating hormone receptor 1 in brown adipose tissue. Annals of the New York Academy of Sciences, 1494(1), 70-86. https://doi.org/10.1111/nyas.14563

Rasul, S., Hartenbach, M., Wollenweber, T., Kretschmer-Chott, E., Grubmüller, B., Kramer, G., Shariat, S., Wadsak, W., Mitterhauser, M., Pichler, V., Vraka, C., Hacker, M., & Haug, A. R. (2021). Prediction of response and survival after standardized treatment with 7400 MBq ¹⁷⁷Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48(5), 1650–1657. https://doi.org/10.1007/s00259-020-05082-5

Hana, C. A., Klebermass, E. M., Balber, T., Mitterhauser, M., Quint, R., Hirtl, Y., Klimpke, A., Somloi, S., Hutz, J., Sperr, E., Eder, P., Jašprová, J., Valášková, P., Vítek, L., Heiss, E., & Wagner, K. H. (2021). Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2. Frontiers in Pharmacology, 11, [636533]. https://doi.org/10.3389/fphar.2020.636533

Sauerzopf, U., Weidenauer, A., Dajic, I., Bauer, M., Bartova, L., Meyer, B., Nics, L., Philippe, C., Pfaff, S., Pichler, V., Mitterhauser, M., Wadsak, W., Hacker, M., Kasper, S., Lanzenberger, R., Pezawas, L., Praschak-Rieder, N., & Willeit, M. (2021). Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia. NeuroImage: Clinical, 32, [102813]. https://doi.org/10.1016/j.nicl.2021.102813

Calabretta, R., Hoeller, C., Pichler, V., Mitterhauser, M., Karanikas, G., Haug, A., Li, X., & Hacker, M. (2020). Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in Large Arteries. Circulation, 142(24), 2396–2398. https://doi.org/10.1161/CIRCULATIONAHA.120.048708

Klebermass, E-M., Mahmudi, M., Miller, A., Pichler, V., Vraka, C., Balber, T., Haschemi, A., Wadsak, W., Hacker, M., Viernstein, H., & Mitterhauser, M. (2020). 2-[F-18]FDG metabolism: The role of alternative metabolic pathways. European Journal of Nuclear Medicine and Molecular Imaging, 47(Suppl 1), S12-S13. [OP-022]. https://doi.org/10.1007/s00259-020-04988-4

Baldinger-Melich, P., Gryglewski, G., Philippe, C., Murgaš, M., James, G. M., Vraka, C., Silberbauer, L., Balber, T., Vanicek, T., Pichler, V., Unterholzner, J., Kranz, G. S., Hahn, A., Winkler, D., Mitterhauser, M., Wadsak, W., Hacker, M., Kasper, S., Frey, R., & Lanzenberger, R. (2020). Corrigendum to "The effect of electroconvulsive therapy on cerebral monoamine oxidase a expression in treatment-resistant depression investigated using positron emission tomography" [Brain Stimul 12 (3) (2019) 714-723]. Brain Stimulation, 13(5), 1280-1281. https://doi.org/10.1016/j.brs.2020.06.009